| LSS . | 1 minute

CMAC welcomes Pfizer Inc as new partner

CMAC (Continuous Manufacturing and Advanced Crystallisation), a pre-competitive consortium led by the University of Strathclyde to accelerate progress in pharmaceutical manufacturing, announces that Pfizer Inc has joined as a strategic member, alongside GSK, AZ, Novartis, Bayer, Takeda, Lilly and Roche.

CMAC is a world-class national centre in advanced pharmaceutical manufacturing, focusing on accelerating the adoption of continuous manufacturing for the production of medicines with a lower cost and improved sustainability.

To read the full article, click here.

Back to News

Do you have news for the Scottish Life Sciences Community?

Submit Your Own News
Top